Posts

Embera NeuroTherapeutics’ Chief Medical Officer, Michael Detke, to Moderate Panel on the Neuroscience of Addiction at BIO CEO & Investor Conference

Michael Detke, M.D., Ph.D., Embera’s Chief Medical Officer, will moderate the “Neuroscience of Addiction: Levers to Attack the Opioid Abuse Crisis” panel at 2018 BIO CEO & Investor Conference. The panel will be held on Tuesday, February 13, 2018, at 9 a.m. EST at the New York Marriott Marquis in New York City.

New Stress Response Modulation Drug Showing Promise in the Treatment of Addiction

Robert Linke, Embera’s president and CEO, spoke with CEOCFO Magazine regarding Embera’s new approach to treating addictions and how attitudes toward addiction are evolving.